Report DMCA Successful management of hemodialysis-dependent refractory myeloma with modified daratumumab, bortezomib and dexamethaso
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.